Eckert v. Roux

39 So. 3d 636, 9 La.App. 5 Cir. 1016, 2010 La. App. LEXIS 407
CourtLouisiana Court of Appeal
DecidedMarch 23, 2010
Docket09-CA-1016
StatusPublished
Cited by5 cases

This text of 39 So. 3d 636 (Eckert v. Roux) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eckert v. Roux, 39 So. 3d 636, 9 La.App. 5 Cir. 1016, 2010 La. App. LEXIS 407 (La. Ct. App. 2010).

Opinion

MARC E. JOHNSON, Judge.

|2Plaintiff, Charles Eckert, appeals from a judgment of the trial court dismissing all of his claims against defendant, Kermit Roux, Jr., for breach of fiduciary duty after finding plaintiff failed to prove defendant exercised gross negligence or a careless disregard for the best interest of Roux and Associates and/or its shareholders. For the reasons that follow, we affirm.

Facts & Procedural History

Roux and Associates was incorporated in December 1970 as a professional medical corporation. The corporation had two members, plaintiff, Dr. Charles Eckert, an anesthesiologist who owned 49 shares of stock, and defendant, Dr. Kermit Roux, Jr., also an anesthesiologist, who owned 51 shares of stock. 1 Dr. Roux served as the president of the corporation and managed the everyday business of the corporation. Dr. Eckert served as secretary of the corporation for a period of time and then later served as the vice president. While Dr. Eckert testified there were no regular shareholder meetings, Dr. Roux testified that informal meetings were held annually.

On April 28, 1989, Dr. Eckert sent a letter to Dr. Roux resigning as a director, an officer and an employee of Roux and Associates. He offered his stock in the corporation and requested he be paid his pro rata share of the corporation’s net worth. Upon his resignation, Dr. Eckert requested an accounting to determine the amount owed to him for his stocks. 2 Both parties agree that Dr. Eckert’s stock was never purchased by Dr. Roux or the corporation and that Dr. Eckert remains owner of the 49 shares. 3

In the summer of 1989, Dr. Eckert retained the services of David Kushner, a certified public accountant, to review the records of Roux and Associates and Jefferson Medical Services, Inc. (JMS), a company responsible for Roux and Associates’ billing and collection, to determine the amounts owed to Dr. Eckert during his employment with Roux and Associates. According to Dr. Eckert, he had suspicions that he had not received his proper share of the corporation’s profits.

At trial, Mr. Kushner testified that he reviewed the books and records of JMS and some of the tax returns of Roux and Associates. He admitted he did not have the complete records of JMS. From the records he reviewed, Mr. Kushner noted several transactions where money collected by JMS was not remitted to Roux and Associates, but rather was loaned to various parties or paid to other parties on behalf of Dr. Roux. He also noted a trans *639 fer account where money collected by JMS was recorded into the transfer account and not the account of Roux and Associates. Although he admitted he did not have the records necessary to trace the funds in and out of the transfer account, Mr. Kushner estimated that ^approximately $10,066,000 was owed to Roux and Associates. Based on his understanding that Dr. Eckert’s share of Roux and Associates was fifty percent, Mr. Kushner opined that Dr. Ec-kert was owed approximately $3.1 million. On cross-examination, Mr. Kushner admitted that if Dr. Eckert knew and approved of the loans made by JMS, Dr. Eckert would need to suffer part of the loss resulting from bad loans that were written off.

In April 1999, Dr. Eckert filed a lawsuit against Dr. Roux and Roux and Associates alleging Dr. Roux had mismanaged the assets of Roux and Associates by diverting fees collected for the corporation to other personal and third party accounts and had breached his fiduciary duty owed to the corporation and to Dr. Eckert. Dr. Eckert further alleged Dr. Roux’s self-dealings had caused direct loss to him.

Defendants filed an exception of no right of action claiming Dr. Eckert did not have a right to individually pursue claims against defendants. The trial court denied the exception, but this Court granted writs and ruled the no right of action should have been granted as to plaintiffs individual claims of breach of fiduciary duty, self-dealing and mismanagement. This Court explained that such claims were properly raised in a shareholder’s derivative action and instructed the trial court to allow plaintiff to amend his petition. This Court maintained plaintiffs individual claim for defendants’ refusal to purchase or redeem his stock. Eckert v. Roux, 00-C-66 (La. App. 5 Cir. 2/24/00), unpublished writ. Plaintiff subsequently amended his petition to assert a shareholder’s derivative claim for breach of fiduciary duty. 4 In his amended petition, plaintiff again asserted individual claims for breach of fiduciary duty, mismanagement and self-dealing, which were again dismissed by the trial court pursuant to defendants’ subsequent exception of no right of action.

The matter proceeded to trial in July 2009. At trial, plaintiff made it clear that he was not making a claim for redemption of his stock. Rather, plaintiff explained his claim was for his share of accounts receivable and 50% of revenues generated by Roux and Associates that he did not receive while employed by Roux and Associates. The trial court concluded plaintiff failed to prove defendant exercised gross negligence or a careless disregard for the best interest of the corporation or its shareholders and dismissed all plaintiffs claims.

Issues

Plaintiff claims the trial court was clearly wrong in denying his claims, both his individual claims and his shareholder derivative claims, against Dr. Roux for breach of fiduciary duty because the evidence was uncontroverted. He maintains Dr. Roux admitted diverting the corporation’s funds for personal gain to the detriment of the corporation and its shareholders. He further contends the trial court erred in applying a negligence standard in determining there was no breach of fiduciary duty.

Law & Analysis

Plaintiffs individual claims for breach of fiduciary duty were dismissed pre-trial in July 2000, when the trial court granted defendant’s exception of no right of action *640 to plaintiffs second supplemental and amending petition, and his shareholder’s derivative claims were dismissed in August 2009, after a trial on the merits.

In their appellee brief, defendants assert the dismissal of plaintiffs individual claims is not properly before this court because the claims were dismissed in 2000 and plaintiff failed to appeal the ruling, and plaintiff failed to | (¡mention the 2000 ruling in his motion to appeal. Defendants further assert the issue regarding plaintiffs right to assert an individual claim for breach of fiduciary duty was previously decided in this Court’s February 24, 2000 writ disposition, which serves as law of the case.

We do not find plaintiff is precluded from challenging the interlocutory judgment of July 2000 granting defendants’ exception of no right of action relating to his individual claims for breach of fiduciary duty in the present appeal. Additionally, we do not find our prior writ disposition constitutes law of the case. Our February 2000 writ disposition, stating that plaintiff did not have an individual right of action, was based on plaintiffs original and first supplemental and amending petitions.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Languirand v. Lopez
261 So. 3d 1054 (Louisiana Court of Appeal, 2018)
Allstate Insurance Co. v. Daniel
177 So. 3d 169 (Louisiana Court of Appeal, 2015)
Guerrero v. Guerrero
110 So. 3d 723 (Louisiana Court of Appeal, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
39 So. 3d 636, 9 La.App. 5 Cir. 1016, 2010 La. App. LEXIS 407, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eckert-v-roux-lactapp-2010.